Updated: June 13, 2026
Updated: June 13, 2026
About the program
Program type
Investment stage
Investment focus areas
Therapeutics
Genomics
Metabolomics
Pharmaceuticals
Mental Health
Therapeutic
Health
Mrna
Digital Health
Proteomics
Medicines
Healthcare
Drugs
Life Sciences
BioTech
CBD
Cell Therapy
HealthTech
Protein
Wellbeing
In Vitro Diagnostics
Biomarkers
Ehealth
Transcriptomics
Pharma
Cannabis
Bio
Connected Health
Healthier Living
Metabolites
Longevity
Psychedelic
Gene Therapy
Telehealth
Drug
Life Sciences Tools
Biopharma
Tech-Enabled Health
Wellness
IVD
CGT
Psychedelics
Description
We are an international venture capital firm.
Location
Investment offer
Funding requirements
We invest in early-stage companies across healthcare, biotech, and other life sciences sectors.